Testing effectiveness (Phase 2)WithdrawnNCT05308602
What this trial is testing
Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years
Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd.